• Amir Qaseem, Timothy J Wilt, Clinical Guidelines Committee of the American College of Physicians, Mary Ann Forciea, Devan Kansagara, Carolyn J Crandall, Nick Fitterman, Lauri A Hicks, Carrie A Horwitch, Jennifer S Lin, Michael Maroto, Robert M McLean, Reem A Mustafa, Jairo Roa, Janice Tufte, and Sandeep Vijan.
• American College of Physicians, Philadelphia, Pennsylvania (A.Q.).
• Ann. Intern. Med. 2019 Sep 3; 171 (5): 354-361.

AbstractOne of the hallmarks of a trustworthy clinical guideline or guidance statement is a comprehensive process for disclosure of interests (DOI) and management of conflicts of interest (COIs). The American College of Physicians (ACP) Clinical Guidelines Committee (CGC) aims to disclose all health care-related interests and manage conflicts in a manner that is transparent, proportional, and consistent. Any person involved in the development of an ACP clinical guideline or guidance statement must disclose all financial and intellectual interests related to health care from the previous 3 years. Persons complete disclosures at the start of their participation and are required to update them over the course of their involvement with the CGC, including before each CGC meeting. A DOI-COI Review and Management Panel reviews the disclosures; flags potential conflicts; grades the COI as low-, moderate-, or high-level; and manages the person's participation accordingly. A high-level COI results in recusal from authorship, voting, and all committee discussions. Participants with a moderate-level COI are recused from authorship and voting for clinically relevant topics but may participate in all discussions. A low-level COI results in no role restrictions. All disclosures and COI management decisions are publicly reported.

9 keywords...

hide…